- Ferlay J, Shin HR, Bray F, et al. (2010) Estimates of world wide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917.
- Simpson HN, McGuire BM (2015) Screening and detection of hepatocellular carcinoma. Clin Liver Dis 19(2):295–307.
- Bruix J, Gores GJ, Mazzaferro V (2014) Hepatocellular carcinoma:clinical frontiers and perspectives. Gut 63(5):844–855 Simpson HN, McGuire BM (2015) Screening and detection of hepatocellular carcinoma. Clin Liver Dis 19(2):295–307.
- Govaere O, Roskams T (2015) Pathogenesis and prognosis of hepatocellular carcinoma at the cellular and molecular levels. Clin Liver Dis 19(2):261–276.
- Casado M, Bosch J, Garcı´a-Paga´n JC, et al. (1998) Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 114(6):1296–1303.
- Sonomura T, Kawai N, Kishi K, et al. (2014) N-butyl cyanoacrylate embolization with blood flow control of an arterioportal shunt that developed after radiofrequency ablation of hepatocellular carcinoma. Korean J Radiol 15(2):250–253.
- EASL: Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., … Vilgrain, V. (2018). Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology, 69(1), 182–236.
- Matsui O, Kobayashi S, Sanada J, Kouda W, Ryu Y, Kozaka K, et al. 2011 Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging;36:264-272.
- Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S. 2005 Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer;103:299-306.
- Kitao A, Zen Y, Matsui O, Gabata T, Nakanuma Y. 2009 Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. Radiology;252:605-614.
- Iwamoto S, Yamaguchi T, Hongo O, Iwamoto H, Sanefuji H. 2010 Excellent outcomes with angiographic subsegmentectomy in the treatment of typical hepatocellular carcinoma: a retrospective study of local recurrence and long-term survival rates in 120 patients with hepatocellular carcinoma. Cancer;116:393-399.
- Kudo, M. (2015). "Molecular Targeted Therapy for Hepatocellular Carcinoma: Where Are We Now?" Liver cancer 4(3): I-VII.
- Shao, W., C. Li, J. Tang, J. Song, Z. Li, J. Sun, Y. Xu, Z. Zheng, J. Cao and L. Zhang (2019 Transarterial). "Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma." Cancer Manag Res 11: 9863-9869.
- Xu, Z. and H. Xie (2019). "The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma." 2019: 8619096.
- Löschner, C., Nagel, S., Kausche, S., & Teichgräber, U. (2015). Hepatic Arterial Supply in 1297 CT-Angiographies. RöFo - Fortschritte Auf Dem Gebiet Der Röntgenstrahlen Und Der Bildgebenden Verfahren, 187(04), 276–282.
- El Sherbiny, W., A. AbdelRahman, M. Diasty and S. W. Shaltout (2016). "Changes in Doppler parameters of portal pressure after interventional management of hepatocellular carcinoma." 41(8): 1532-1538.
- Shin, S. W. (2009). "The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma." Korean J Radiol 10(5): 425-434.
- Bolognesi, M., D. Sacerdoti, C. Merkel, G. Gerunda, A. Maffei-Faccioli, P. Angeli, R. M. Jemmolo, G. Bombonato and A. Gatta (1996). "Splenic Doppler impedance indices: influence of different portal hemodynamic conditions." Hepatology 23(5): 1035-1040.
- Iwakiri, Y. and R. J. Groszmann (2006). "The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule." Hepatology 43(2 Suppl 1): S121-131.
- Grant EG, Schiller VL, Millener P, et al. 1992 Color Doppler imaging of the hepatic vasculature. AJR Am J Roentgenol ; 159:943-950.
- Zhang, L., Y. Y. Duan, J. M. Li and J. K. Yin (2007). "Hemodynamic features of Doppler ultrasonography in patients with portal hypertension: intraoperative direct measurement of portal pressure in the portal venous system." J Ultrasound Med 26(12): 1689-1696.
- Huang, T. L., T. Y. Chen, L. L. Tsang, H. Y. Ou, C. Y. Yu, C. C. Wang, S. H. Wang, C. C. Lin, Y. W. Liu, C. C. Yong, K. W. Chiu, H. L. Eng, B. Jawan, Y. F. Cheng and C. L. Chen (2012). "Hemodynamics of portal venous stenosis before and after treatment in pediatric liver transplantation: evaluation with Doppler ultrasound." Transplant Proc 44(2): 481-483.
- Benvegnù, L., & Alberti, A. (2001). Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis. Antiviral Research, 52(2), 199–207.
- Kok, K., Naylor, S. L., & Buys, C. H. C. M. (1997). Deletions of the Short Arm of Chromosome 3 in Solid Tumors and the Search for Suppressor Genes. Advances in Cancer Research, 27–92.
- Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S. 2005 Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer;103:299-306.
- Xu, Z. and H. Xie (2019). "The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma." 2019: 8619096.
- Grant EG, Schiller VL, Millener P, et al. 1992 Color Doppler imaging of the hepatic vasculature. AJR Am J Roentgenol ; 159:943-950.
- Chan, A. O., M. F. Yuen, C. K. Hui, W. K. Tso and C. L. Lai (2002). "A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma." Cancer 94(6): 1747-1752.
- Jeon, S. H., K. S. Park, Y. H. Kim, Y. S. Shin, M. K. Kang, B. K. Jang, W. J. Chung, K. B. Cho and J. S. Hwang (2007). "[Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma]." Korean J Gastroenterol 50(3): 176-182.
- Tasneem, A. A., Z. Abbas, N. H. Luck, S. M. Hassan and S. M. Faiq (2013). "Adverse events following transarterial chemoembolization for hepatocellular carcinoma and factors predicting such events." J Pak Med Assoc 63(2): 239-244.
- Shao, W., C. Li, J. Tang, J. Song, Z. Li, J. Sun, Y. Xu, Z. Zheng, J. Cao and L. Zhang (2019 Transarterial). "Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma." Cancer Manag Res 11: 9863-9869.
- Kaplan, D. E., R. Mehta, K. D'Addeo, T. P. Gade and T. H. Taddei (2018). "Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching." Journal of vascular and interventional radiology : JVIR 29(4): 540-549.e544.
|